MadeMed logo

MadeMed Review

7.4
★★★★☆3.7/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10

Best for: compounded GLP-1 in both injection and oral forms

MadeMed scores highest on the strength of its clinical program: drug options and dosing support.

Semaglutide

$179/mo

Tirzepatide

$249/mo

Price checked on MadeMed’s site,

What the monthly price covers

Medication

Not stated

Provider visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

PartnerMadeMed is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money

MadeMed (MadeMed LLC, based in Houston, Texas) is a LegitScript-certified telehealth platform selling compounded semaglutide and tirzepatide injections and a tirzepatide sublingual tablet, alongside hair, hormone, sexual-health and longevity treatments. Each product page lists one price at every dose: semaglutide is $179 and tirzepatide $249 billed every 30 days, with lower monthly rates on 90- and 360-day plans and a $20 consultation fee. It names its partner pharmacies and publishes a customer support line.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedOral OptionSemaglutideTirzepatideLegitScript VerifiedTelehealth-only

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

MadeMed logo
3.7 / 5
Our editorial rating
Visit MadeMed →

from $179/mo · no insurance needed

MadeMed at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$179/mo
FDA status
No FDA warning letter on record

How we scored MadeMed

Each dimension is scored algorithmically from MadeMed’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.5/10

At $179/mo, MadeMed runs in line with the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).

Effectiveness25%

8.4/10

MadeMed offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

7.4/10

Online intake and platform experience; 6 platform features disclosed.

Trust & Safety15%

7.2/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

6.3/10

MadeMed's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

6.1/10

MadeMed provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this MadeMed review

Last checked November 2026
  • Confirmed current pricing across 3 dose/plan tiers
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$179–$249/mo across 3 dose/plan tiers (checked November 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with MadeMed

We walked MadeMed’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Browse treatments with prices shown up front (Injectable Semaglutide from $143/mo, Injectable Tirzepatide from $199/mo, Tirzepatide Sublingual Tablet from $199/mo on the 360-day plan)
  2. 2Complete a quick online visit about your health history (no video call required)
  3. 3A U.S.-licensed, board-certified physician reviews your information to decide if a prescription is appropriate
  4. 4If approved, your treatment ships discreetly and free from a licensed U.S. compounding pharmacy
  5. 5Message the medical team any time through the secure messaging portal
Price shown before you start
  • LegitScript-certified telehealth; consultations reviewed by board-certified U.S. physicians licensed in your state
  • Prices are shown up front on each product page: semaglutide $179 and tirzepatide $249 billed every 30 days, with lower rates on 90- and 360-day plans
  • Does not accept insurance; product pages say HSA/FSA may apply
  • Fully asynchronous: no live video visit and no lab work required to get started
  • Medications compounded and shipped from licensed, accredited U.S. pharmacies

GLP-1 medications MadeMed offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Peptides MadeMed offers

Beyond GLP-1s, MadeMed also offers these peptides. Tap any for our evidence-based guide.

Pricing

Prices re-verified

Injectable: billed every 30 days, same price at every doseCompounded
$179/mo
semaglutide

$179 billed every 30 days, $161 a month on the 90-day plan (billed $483), or $143 a month on the 360-day plan (billed $1,718). A $20 consultation fee ($30 for a video visit) applies.

Injectable: billed every 30 days, same price at every doseCompounded
$249/mo
tirzepatide

$249 billed every 30 days, $224 a month on the 90-day plan (billed $672), or $199 a month on the 360-day plan (billed $2,390). A $20 consultation fee ($30 for a video visit) applies.

Sublingual tablet (3 mg): billed every 30 daysCompounded · oral
$249/mo
tirzepatide

$249 billed every 30 days, $224 a month on the 90-day plan (billed $672), or $199 a month on the 360-day plan (billed $2,390). A $20 consultation fee applies.

Ready to get started?

Plans and promotions change often, so check MadeMed's current pricing and active discounts before you decide.

See MadeMed pricing →

What we like

  • Three GLP-1 options, including a compounded tirzepatide sublingual tablet for people who would rather avoid needles
  • LegitScript certification badge on the homepage
  • Customer phone support published (1-800-582-1428), which is uncommon among chat-only competitors

Watch-outs

  • A $20 consultation fee ($30 for a video visit) is charged even if no prescription is issued
  • Only the oral tirzepatide page lists states (40, excluding AL, AK, AR, HI, MA, MO, NM, NY, SC and VA); injectable coverage isn't stated
  • No individual medical director named; the Terms name only the medical group, MDI Medical Group PC
  • Terms require binding individual arbitration and waive class actions

MadeMed in one line: flat GLP-1 pricing at every dose, with a tablet option for tirzepatide

MadeMed is a direct-to-consumer telehealth platform, run by MadeMed LLC of Houston, Texas, that sells compounded semaglutide and tirzepatide injections plus a tirzepatide tablet that dissolves under the tongue. That tablet matters if you dread needles, because most GLP-1 services hand you a syringe and call it a day. Each product page prints one price for every dose, so you can see what you'll pay before you start a consult. The main add-on is a small consultation fee on each order.

How the pricing works

MadeMed prices by billing cycle, not by dose. Compounded semaglutide is $179 billed every 30 days, with lower monthly rates on a 90-day plan and $143 a month on a 360-day plan. Tirzepatide, injection or tablet, is $249 every 30 days and drops to $199 a month on the 360-day plan. The product pages say the price stays the same from the starting dose to the top one, which removes the usual jump as you titrate up.

  • Budget for the consult: each order carries a $20 consultation fee ($30 if a video visit is needed), and it is kept even if you are not prescribed.
  • Know what a long plan commits you to: the 360-day rate is the cheapest, but it is billed as one charge, and MadeMed's terms give no prorated refunds after you cancel.
  • Pausing and canceling: its FAQ says you can pause or cancel from your account, and cancellation takes effect at the end of the current billing period.

The medications: a tablet option for tirzepatide

The weight-loss menu has three GLP-1 products: injectable semaglutide, injectable tirzepatide, and a 3 mg tirzepatide sublingual tablet. Tirzepatide is the dual-action drug behind the strongest weight-loss numbers in trials. A needle-free version of it is still uncommon. MadeMed does not sell an oral semaglutide, so the tablet is the only route for someone who wants to avoid injections.

The tablet carries a caveat: compounded tablets taken under the tongue have not been tested in large trials, and peptides absorbed that way are generally less efficient than injections. Ask the prescribing doctor how the tablet compares with the shot before you assume they deliver the same result.

What MadeMed discloses, and what it doesn't

MadeMed displays a LegitScript certification badge and links to LegitScript's own lookup, so you can check the listing yourself. It names the 503A compounding pharmacies it partners with (Absolute RX, Strive Pharmacy, ERX Hub, and Southend Pharmacy) and publishes a support phone line (1-800-582-1428), which suggests a human is reachable if something goes wrong with your order. Its terms name the medical group, MDI Medical Group PC, and set Texas law with binding individual arbitration for disputes.

  • No named medical director: the site says board-certified physicians licensed in your state review each consult, and the terms name the medical group, but no individual clinical leader is named.
  • A partial state list: the tirzepatide tablet page says it's offered in 40 states and not in Alabama, Alaska, Arkansas, Hawaii, Massachusetts, Missouri, New Mexico, New York, South Carolina or Virginia. The injection pages don't list states, so confirm yours before you start.
  • No pharmacy match: the site names four partner pharmacies but doesn't say which one will fill your order.

Who should consider MadeMed, and who shouldn't

Consider it if you want a flat price that won't rise with your dose, or a tirzepatide tablet instead of a weekly shot. The published prices, named pharmacies, and live phone line put it ahead of the more anonymous compounding sellers. People who want to see how much of their loss is fat versus muscle can look at HumeCare+, which includes a body-composition device with its flat-priced compounded plans. Worth knowing: it doesn't show a price until you finish its intake quiz.

Skip it if you want oral semaglutide, which it doesn't sell, or if a named medical director is non-negotiable for you. If you live in one of the 10 states where the tablet isn't offered, it's injections only, and for those the site doesn't list states, so ask support first. If you're in perimenopause or menopause and want insurance in the picture, Midi Health serves all 50 states and can prescribe a GLP-1 within its menopause care, at the clinician's discretion. You can see how we weigh transparency and oversight in our scoring methodology.

Trust and safety: good signals, a few gaps

There are no FDA warning letters on file for MadeMed, and the LegitScript certification, named 503A pharmacies, and published phone support are legitimate positives. The gaps that remain are the unnamed individual medical director and the missing state list for the injections. None of that means MadeMed is unsafe. Ask about both before you order.

Bottom line

MadeMed gives you a clear price before you start: $179 every 30 days for semaglutide and $249 for tirzepatide, the same at every dose, plus a $20 consult fee. Its tirzepatide tablet gives needle-averse patients a choice of format. The partner pharmacies are named. Confirm the format you want is offered in your state and ask which pharmacy will fill your prescription, and it can be a fair option.

The Bottom Line

MadeMed scores highest on the strength of its clinical program: drug options and dosing support.

Score: 7.4/10Best for: compounded GLP-1 in both injection and oral formsFrom: $179/mo

Ready to start with MadeMed?

From $179/mo. See current pricing and start your free consultation.

MadeMed might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Alternatives to MadeMed

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →

Head-to-head

Compare MadeMed vs…

MadeMed scores7.4/10

Side-by-side pricing, medications and scores. Pick a matchup.

All 45 MadeMed comparisons

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

MadeMed is a direct-to-consumer telehealth platform, run by MadeMed LLC of Houston, Texas, that offers compounded GLP-1 medications alongside hair, hormone, sexual-health and longevity treatments. Its weight-loss line has three GLP-1 products: injectable semaglutide, injectable tirzepatide, and a tirzepatide sublingual tablet, which gives needle-averse patients one oral alternative. MadeMed displays a LegitScript certification badge and publishes a customer phone number (1-800-582-1428). Compounded semaglutide and tirzepatide from MadeMed are not FDA-approved as finished drug products.
MadeMed displays a LegitScript certification badge, and its About page links to LegitScript's own lookup so you can check the listing yourself. It names its operating company (MadeMed LLC, Houston, Texas), its medical group (MDI Medical Group PC), its partner compounding pharmacies, and a public support phone number (1-800-582-1428). It does not name an individual medical director. Its oral tirzepatide tablet is offered in 40 states, not Alabama, Alaska, Arkansas, Hawaii, Massachusetts, Missouri, New Mexico, New York, South Carolina or Virginia, but the injectable pages don't list states, so confirm yours before you start.
MadeMed lists its prices on each product page, at one price for every dose. Compounded semaglutide injection is $179 billed every 30 days, $161 a month on a 90-day plan, or $143 a month on a 360-day plan. Compounded tirzepatide, injectable or sublingual, is $249 every 30 days, $224 a month on a 90-day plan, or $199 a month on a 360-day plan. Each order adds a $20 consultation fee ($30 if a video visit is needed), which is kept even if you are not prescribed.
MadeMed does not currently sell an oral semaglutide. Its only needle-free GLP-1 is a compounded tirzepatide sublingual tablet (3 mg), which is custom-made by a compounding pharmacy and is not FDA-approved as a finished drug product. The FDA-approved oral semaglutide tablet is Rybelsus, made by Novo Nordisk, which uses an absorption enhancer (SNAC) and has clinical trial data behind it. Compounded tablets that dissolve under the tongue have not been studied in large trials, so discuss the evidence with your prescribing clinician before choosing a tablet over an injection.
MadeMed names its partner compounding pharmacies: Absolute RX, Strive Pharmacy, ERX Hub, and Southend Pharmacy. Its product pages describe them as state-licensed 503A pharmacies working to USP standards. The site does not say which one fills a given prescription, so ask the support team (1-800-582-1428) before ordering if that matters to you.
MadeMed can be reached by phone at 1-800-582-1428, by email at support@mademed.com, or through the patient portal. Its FAQ says you can pause or cancel at any time from your account or through support. Under its terms, cancellation takes effect at the end of the current billing period, with no prorated refunds.
MadeMed doesn't use public promo or coupon codes. Third-party sites advertising "MadeMed discount codes" are typically fake; any current offer applies automatically through the link on this page.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for MadeMed. The concerns our review flags: A $20 consultation fee ($30 for a video visit) is charged even if no prescription is issued; Only the oral tirzepatide page lists states (40, excluding AL, AK, AR, HI, MA, MO, NM, NY, SC and VA); injectable coverage isn't stated; No individual medical director named; the Terms name only the medical group, MDI Medical Group PC; Terms require binding individual arbitration and waive class actions. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this MadeMed review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See MadeMed's current pricing

Plans from $179/mo. Start your free consultation to check eligibility and today's price.